RNTX
Rein Therapeutics Inc
0.825$
+3.0%
vs. previous close
Closing price · As of: Oct 5, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | +333.3% | +13.5% | -93.2% | -100.0% | – | – | – | -100.0% | – | – | – | – | |
| – | +17.9% | -44.4% | +117.3% | +55.8% | -73.8% | +98.5% | -3.0% | +465.2% | -82.2% | -39.3% | +5.1% | – | |
| – | – | – | -86.3% | +581.6% | -163.4% | – | – | +26.5% | -239.8% | – | -326.3% | – | |
| – | – | -100.0% | – | – | – | – | – | – | – | – | – | – | |
| – | -117.7% | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | – | – | -225.0% | – | |
| – | – | -100.0% | – | -102.4% | – | +73,700.0% | +538.5% | -59.7% | +26.6% | +93.5% | +927.4% | – | |
| – | – | -200.5% | – | -143.2% | – | – | – | – | – | – | +233.1% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.